Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

cbdMD (YCBD) EBT Margin (2016 - 2025)

Historic EBT Margin for cbdMD (YCBD) over the last 10 years, with Q3 2025 value amounting to 14.4%.

  • cbdMD's EBT Margin fell 110500.0% to 14.4% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.63%, marking a year-over-year increase of 79400.0%. This contributed to the annual value of 10.63% for FY2025, which is 79400.0% up from last year.
  • cbdMD's EBT Margin amounted to 14.4% in Q3 2025, which was down 110500.0% from 19.43% recorded in Q2 2025.
  • cbdMD's 5-year EBT Margin high stood at 14.45% for Q2 2021, and its period low was 356.72% during Q2 2022.
  • Over the past 5 years, cbdMD's median EBT Margin value was 27.39% (recorded in 2023), while the average stood at 73.85%.
  • In the last 5 years, cbdMD's EBT Margin tumbled by -3711700bps in 2022 and then surged by 3293300bps in 2023.
  • Quarter analysis of 5 years shows cbdMD's EBT Margin stood at 194.39% in 2021, then skyrocketed by 67bps to 63.39% in 2022, then skyrocketed by 71bps to 18.54% in 2023, then surged by 102bps to 0.3% in 2024, then tumbled by -4979bps to 14.4% in 2025.
  • Its EBT Margin was 14.4% in Q3 2025, compared to 19.43% in Q2 2025 and 10.12% in Q1 2025.